Modella AI, illumiSonics Advance AI in Virtual Pathology
Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, and illumiSonics Inc., a leader in label-free optical imaging and computational pathology, today announced successful research demonstrating compatibility between illumiSonics’ research-use only Multi-Laser Imaging (MLI) system and Modella AI’s research-use only PathChat DX platform, which has been granted a Breakthrough Device Designation by…
